Uptravi (SelexiPag): The Users Drug Registry (SPHERE)

Brief description of study

An observational research study is a study that follows you during your normal course of medical care for your condition while on Uptravi. There are no additional tests or procedures as part of this observational drug registry study. Participating in an observational research study will not change the regular medical care you get. The purpose of a research study is to collect and analyze information, which may help patients get better care in the future. The purpose of this study is to better understand the demographic and clinical characteristics of patients treated with Uptravi; we hope to learn about the dosing and titration patterns (increase and decrease of drug dose) of Uptravi (including any medication changes from other PAH specific drugs to Uptravi and from Uptravi to other prostanoids – drugs used to treat swelling and allergic reactions), and to describe the clinical course of patients treated with Uptravi.


Clinical Study Identifier: s18-00881
ClinicalTrials.gov Identifier: NCT03278002


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.